This finding produced a significant difference in the 5-year survival rate between patients with tumours positive or negative for CD133 expression (P=0.0002; Figure 6), and between patients with more or less than 5% cells expressing CD133 (P=0.0366; Figure 6). Here, PROM1 is linked to neoplasm.